Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B10 | O60218 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.38 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.38 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.38 |
| ▸ | BACE1 | P56817 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | PPARG | P37231 | 1/20 | 0.34 |
| ▸ | PPARD | Q03181 | 1/20 | 0.34 |
| ▸ | PPARA | Q07869 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | TRPM7 | Q96QT4 | 1/20 | 0.31 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15224326 | 1.00 | AKR1B10 (0.38) | AKR1B10MMP2AKR1B1AKR1C3PAK1 | |
| SCHEMBL15224306 | 0.92 | AKR1B10 (0.44) | AKR1B10MMP2AKR1B1AKR1C3PAK1 | |
| SCHEMBL15281214 | 0.82 | AKR1B10 (0.34) | AKR1B10MMP2AKR1B1AKR1C3PAK1 | |
| SCHEMBL15224319 | 0.79 | AKR1B10 (0.33) | AKR1B10MMP2AKR1B1AKR1C3PAK1 | |
| SCHEMBL15224301 | 0.79 | AKR1B10 (0.33) | AKR1B10MMP2AKR1B1AKR1C3PAK1 | |
| SCHEMBL12846394 | 0.76 | BACE1 (0.48) | BACE1PPARGPPARDPPARAPTPN1 | |
| SCHEMBL15224346 | 0.75 | AKR1B10 (0.40) | AKR1B10MMP2AKR1B1AKR1C3PAK1 | |
| SCHEMBL15224305 | 0.75 | AKR1B10 (0.40) | AKR1B10MMP2AKR1B1AKR1C3PAK1 | |
| SCHEMBL15224329 | 0.73 | AKR1B10 (0.42) | AKR1B10MMP2AKR1B1AKR1C3PAK1 | |
| SCHEMBL15224328 | 0.73 | AKR1B10 (0.42) | AKR1B10MMP2AKR1B1AKR1C3PAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2633886-B1 | COMPOUNDS AND MIXTURES INFLUENCING INFLAMMATORY STATES | SYMRISE AG (DE) | 2018-01-31 | — | — | EP | disclosed |
| US-8906958-B2 | Compounds and mixtures for influencing inflammatory states | SYMRISE AG (DE) | 2014-12-09 | — | — | US | disclosed |
| US-20130251730-A1 | Compounds and Mixtures Influencing Inflammatory States | SYMRISE AG (DE) | 2013-09-26 | — | — | US | disclosed |
| US-20130236472-A1 | COMPOUNDS AND MIXTURES FOR INFLUENCING INFLAMMATORY STATES | SYMRISE AG (DE) | 2013-09-12 | — | — | US | disclosed |
| EP-2633886-A1 | Compounds and mixtures influencing inflammatory states | Symrise AG (DE) | 2013-09-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130251730-A1 | Compounds and Mixtures Influencing Inflammatory States | MSR1, MPO, IL1B | AKR1B10 503/4885MMP2 1065/4885AKR1B1 434/4885 |
| US-20130236472-A1 | COMPOUNDS AND MIXTURES FOR INFLUENCING INFLAMMATORY STATES | TNF, CXCL8, IL1B | AKR1B10 842/4885MMP2 482/4885AKR1B1 638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.